The Wayback Machine - https://web.archive.org/web/20121020172424/http://en.wikipedia.org/wiki/5-MeO-DALT

5-MeO-DALT

From Wikipedia, the free encyclopedia
Jump to: navigation, search
5-MeO-DALT
Systematic (IUPAC) name
N-allyl-N-[2-(5-methoxy
-1H-indol-3-yl)ethyl]
prop-2-en-1-amine
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 928822-98-4 YesY
ATC code  ?
PubChem CID 50878551
ChemSpider 21106245 YesY
Chemical data
Formula C17H22N2O 
Mol. mass 270.375 g/mol
 YesY (what is this?)  (verify)

5-MeO-DALT or N,N-diallyl-5-methoxytryptamine is a psychedelic tryptamine first synthesized by Alexander Shulgin.

Contents

[edit] Chemistry

The full name of the chemical is N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine. It is chemically related to the compounds 5-MeO-DPT and DALT.

[edit] History

The first material regarding the synthesis and effects of 5-MeO-DALT was sent from Alexander Shulgin to a researcher named Murple in May 2004, after which it was circulated online. In June 2004 5-MeO-DALT became available from internet research chemical vendors. In August 2004 the synthesis and effects of 5-MeO-DALT were published by Erowid. [1]

[edit] Dosage

Doses ranging from 12-20 mg were tested by Alexander Shulgin's research group. [2]

[edit] Dangers

There are numerous anecdotal reports of users consuming dosages far in excess of those tested by Alexander Shulgin, although there is no published literature on the toxicity of 5-MeO-DALT. By far, the most dangerous effect seems to be retrograde amnesia from consuming excess amounts of this material.

[edit] Legality

5-MeO-DALT is unscheduled in the United States. It is also legal in the UK because the allyl group is not an alkyl group, which the law requires for a tryptamine to be illegal. 5-MeO-DALT became a controlled substance in Japan from April of 2007, by amendment to the Pharmaceutical Affairs Law.[3]

[edit] Notes

  1. ^ [1], Morris, H. (11 May 2010). "The Last Interview With Alexander Shulgin". Vice Magazine. Retrieved 2011-02-24.
  2. ^ [2]
  3. ^ "厚生労働省:平成18年度無承認無許可医薬品等買上調査の結果について". http://www.mhlw.go.jp/houdou/2007/08/h0810-3.html. Retrieved 2012-06-26.  (Japanese)

[edit] External links

Personal tools
Namespaces

Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Languages
Morty Proxy This is a proxified and sanitized view of the page, visit original site.